Treatment with opioid antagonists and mTOR inhibitors
US9526723B2 · kind B2 · utility
7Cited by
155References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 12, 2014 |
| Grant date | Dec 27, 2016 |
| Priority date | — |
| Expiry date | Feb 12, 2034 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Embodiments of the invention provide methods of treating a disorder or disease characterized by cellular proliferation and migration by co-administering a synergistically effective amount of an mTOR inhibitor and a μ-opioid receptor antagonist.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.